Revance AestheticsArticles & NewsNewsNew Survey: 74% of Women Report Greater Interest in Aesthetic Treatments After MenopauseMenopause transforms beauty priorities: 74% of women demand specialized aesthetic care solutionsHomeDAXXIFY Targets Frown Lines With Peptide-Formulated NeurotoxinRevolutionary peptide formula erases frown lines in just two days with six-month durability.HomeRevance Appoints New Chief Marketing Officer, SkincareHomeRevance Announces Julianne Hough as the Celebrity Brand Partner for DAXXIFY Brand InjectableRevance names Julianne Hough as DAXXIFY's newest brand partner to boost consumer education and patient demand.HomeSkinPen Surpasses 1 Million Treatments as Microneedling Demand AcceleratesRevance surpasses 1 million SkinPen treatments as microneedling demand continues to surge.HomeQ&A: Revance's New CEO Nadeem Moiz Charts Bold Vision After Crown AcquisitionThe newly appointed CEO Nadeem Moiz uncovers his vision for the future of aesthetics, skincare and brand evolution since Crown Laboratories' aquisition of Revance.